Supriya Lifescience Limited (SUPRIYA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 45.23B |
| Enterprise Value | 44.49B |
| P/E Ratio | 32.95 |
| PEG Ratio | 2.91 |
| Price/Sales Ratio | 8.32 |
| Price/Book Ratio | 5.75 |
| Enterprise/Revenue | 8.23 |
| Enterprise/EBITDA | 22.6 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.25 |
| Operating Margin | 0.32 |
AD
Management Effectiveness
| Return On Assets | 0.15 |
| Return On Equity | 0.19 |
Income Statement
| Revenue | 8.28B |
| Revenue/Share | 102.83 |
| Gross Profit | 4.49B |
| EBITDA | 3.05B |
| Net Income | 2.09B |
| Diluted EPS | 25.98 |
Balance Sheet
| Total Cash | 788.67M |
| Total Cash/Share | 9.8 |
| Total Debt | 54.35M |
| Total Debt/Equity | 0 |
| Current Ratio | 4.4 |
| Book Value Per Share | 148.77 |
Price History
| 52-Week Change | 19.75 |
| 52-Week High | 1,085 |
| 52-Week Low | 545.5 |
| Moving Average 50 Days | 857.65 |
| Moving Average 200 Days | 737.43 |
Statistics
| Average Volume | 581,987 |
| Shares Outstanding | 80.48M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 0.12 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
